¼¼°èÀÇ ¼öÀÇ ¼øÈ¯±âÇÐ ½ÃÀå
Veterinary Cardiology
»óǰÄÚµå : 1777666
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 466 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,180,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,541,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ ¼öÀÇ ¼øÈ¯±âÇÐ ½ÃÀåÀº 2030³â±îÁö ¹Ì±¹¿¡¼­ 42¾ï ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2024³â¿¡ 27¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ¼¼°èÀÇ ¼öÀÇ ¼øÈ¯±âÇÐ ½ÃÀåÀº 2024-2030³â¿¡ CAGR 7.5%·Î ¼ºÀåÇϸç, 2030³â¿¡´Â 42¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ ¸®Æ÷Æ®¿¡¼­ ºÐ¼®µÇ°í ÀÖ´Â ºÎ¹®ÀÇ ÇϳªÀÎ ¹Ý·Áµ¿¹°Àº CAGR 8.8%¸¦ ±â·ÏÇϸç, ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 28¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ°í ÀÖ½À´Ï´Ù. »ý»ê µ¿¹° ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ Áß CAGR 5.0%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 7¾ï 3,740¸¸ ´Þ·¯·Î ÃßÁ¤µÇ´Â ÇÑÆí, Áß±¹Àº CAGR 11.9%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹Ãø

¹Ì±¹ÀÇ ¼öÀÇ ¼øÈ¯±âÇÐ ½ÃÀåÀº 2024³â¿¡ 7¾ï 3,740¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 8¾ï 9,360¸¸ ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³âÀÇ CAGRÀº 11.9%ÀÔ´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ Áß CAGRÀº °¢°¢ 3.6%¿Í 7.3%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 4.9%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ ¼öÀÇ ¼øÈ¯±âÇÐ ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

¼öÀÇ ¼øÈ¯±âÇÐÀÌ ¹Ý·Áµ¿¹° °Ç°­°ü¸®ÀÇ ÇÑ ÃàÀ» ´ã´çÇϰí ÀÖ´Â ÀÌÀ¯´Â ¹«¾ùÀΰ¡?

¹Ý·Áµ¿¹°ÀÇ ½ÉÀå °ü·Ã ÁúȯÀÇ À¯º´·ü Áõ°¡¿Í Á¶±â Áø´Ü ¹× Áö¼ÓÀûÀÎ ½ÉÀå °ü¸®ÀÇ Á߿伺¿¡ ´ëÇÑ º¸È£ÀÚµéÀÇ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó ¼öÀÇ ¼øÈ¯±âÇÐÀº µ¿¹° °Ç°­°ü¸®ÀÇ Áß¿äÇÑ Àü¹® ºÐ¾ß·Î ºÎ»óÇϰí ÀÖ½À´Ï´Ù. ¿µ¾ç»óÅÂÀÇ °³¼±, ¿¹¹æÀÇÇÐ, ÷´ÜÀÇ·á·Î ¹Ý·Áµ¿¹°ÀÇ ¼ö¸íÀÌ ±æ¾îÁö¸é¼­ ¿ïÇ÷¼º½ÉºÎÀü, ºÎÁ¤¸Æ, ÆÇ¸·Áõ, ¼±Ãµ¼º ±âÇü µî ³ëÈ­¿¡ µû¸¥ ½ÉÇ÷°ü°è ÁúȯÀÌ ÈçÇØÁö°í ÀÖ½À´Ï´Ù. Ä«¹ß¸®¾î, Å· Âû½º ½ºÆÐ´Ï¾ó, º¹¼­, µµº£¸£¸¸, µµº£¸£¸¸ ÇɼеîÀÇ °ßÁ¾°ú ƯÁ¤ °í¾çÀÌ Ç°Á¾Àº À¯ÀüÀûÀ¸·Î ½ÉÀåÁúȯÀÌ ¹ß»ýÇϱ⠽¬¿ö Àü¹®ÀûÀÎ Ä¡·á°¡ ÇÊ¿äÇÕ´Ï´Ù. ¼öÀÇ»ç ½ÉÀåÀü¹®ÀÇ¿Í ÀϹÝÀÇ ¸ðµÎ ½ÉÃÊÀ½ÆÄ, ½ÉÀüµµ(ECG), ¿¢½º·¹ÀÌ ¿µ»ó, ½ÉÀå ¹ÙÀÌ¿À¸¶Ä¿ °Ë»ç µîÀÇ Áø´ÜÀ» ÇÊ¿ä·Î ÇÏ´Â µ¿¹°ÀÇ ¼ö°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¹Ý·Áµ¿¹° º¸È£ÀÚµéÀº µ¿¹°À» °¡Á·ÀÇ ÀÏ¿øÀ¸·Î ¿©±â°Ô µÇ¾ú°í, »îÀÇ ÁúÀ» Çâ»ó½ÃŰ°í ¼ö¸íÀ» ¿¬ÀåÇϱâ À§ÇØ º¸´Ù Àû±ØÀûÀ¸·Î ÷´Ü Áø´Ü°ú Ä¡·áÀû °³ÀÔÀ» Çϰí ÀÖ½À´Ï´Ù. ÀÌó·³ µ¿¹°ÀÇ °Ç°­°ú Àü¹®ÀûÀÎ Áø·á¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁü¿¡ µû¶ó Àü ¼¼°è µµ½Ã Áö¿ªÀÇ Áø·á¼Ò, Àü¹®º´¿ø, Çмú µ¿¹°º´¿ø¿¡¼­ ¼öÀÇ ¼øÈ¯±âÇÐ ¼­ºñ½º¿¡ ´ëÇÑ ¼ö¿ä°¡ Å©°Ô Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

Áø´Ü ¹× ¿µ»ó Áø´ÜÀÇ Çõ½ÅÀº µ¿¹° ½ÉÀå Ä¡·á¸¦ ¾î¶»°Ô °³¼±Çϰí Àִ°¡?

±â¼ú Çõ½ÅÀº µ¿¹°ÀÇ ½ÉÇ÷°ü ÁúȯÀÇ Á¶±â ¹ß°ß, ´õ Á¤È®ÇÑ Áø´Ü, ´õ ³ªÀº ¸ð´ÏÅ͸µÀ» °¡´ÉÇÏ°Ô ÇÏ´Â ¼öÀÇ ¼øÈ¯±âÇÐÀÇ ÇüŸ¦ ¹Ù²Ù°í ÀÖ½À´Ï´Ù. ÃֽнÉÃÊÀ½ÆÄ Àåºñ´Â ÇöÀç ¼öÀÇÇпëÀ¸·Î Á¶Á¤µÈ µµÇ÷¯ ±â¹Ý °íÇØ»óµµ À̹ÌÁö¸¦ Á¦°øÇÏ¿© ÀÓ»óÀǰ¡ Ç÷·ù, ÆÇ¸· ±â´É, ½É½Ç Å©±â¸¦ Á¤È®ÇÏ°Ô Æò°¡ÇÒ ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù. ÈÞ´ë¿ë ¹«¼± ½ÉÀüµµ ½Ã½ºÅÛÀº ÀÓ»ó ÇöÀåÀ̳ª °¡Á¤¿¡¼­ ½É¹Ú¼ö ºÐ¼®À» ¿ëÀÌÇÏ°Ô Çϰí, ÀÏ¹Ý Áø·á¼Ò³ª À̵¿ ¼­ºñ½º¿¡¼­ Áø´Ü¿¡ ´ëÇÑ Á¢±Ù¼ºÀ» Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù. NT-proBNP¿Í Æ®·ÎÆ÷´Ñ°ú °°Àº ½ÉÀå ¹ÙÀÌ¿À¸¶Ä¿´Â ½ÉÀåÁúȯÀÇ ¼±º°, º´±âºÐ·ù, ¸ð´ÏÅ͸µ¿¡ Á¡Á¡ ´õ ¸¹ÀÌ È°¿ëµÇ°í ÀÖÀ¸¸ç, ¿µ»ó Áø´ÜÀ» º¸¿ÏÇÏ´Â ÃÖ¼Òħ½ÀÀûÀÎ ¹æ¹ýÀ¸·Î Ȱ¿ëµÇ°í ÀÖ½À´Ï´Ù. 3D ½ÉÃÊÀ½ÆÄ, ÄÄÇ»ÅÍ´ÜÃþÃÔ¿µ(CT), ÀÚ±â°ø¸í¿µ»ó¹ý(MRI)°ú °°Àº ÷´Ü ¿µ»ó Áø´Ü ÅøÀº ƯÈ÷ º¹ÀâÇÑ Áõ·Ê¿¡ ´ëÇØ µ¿¹°º´¿ø ÀÇ·Ú¼¾ÅÍ¿¡¼­ ³Î¸® º¸±ÞµÇ°í ÀÖ½À´Ï´Ù. ¿ø°ÝÀÇ·áµµ ¼öÀÇ ¼øÈ¯±âÇп¡¼­ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖÀ¸¸ç, °³¾÷Àǰ¡ ¿ø°ÝÀ¸·Î Àü¹®ÀÇ¿Í »ó´ãÇϰųª ½ÉÀüµµ³ª ÃÊÀ½ÆÄ °á°ú¸¦ ½Å¼ÓÇÏ°Ô ÇØ¼®ÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú °³¹ßÀº ¿öÅ©Ç÷ο츦 °£¼ÒÈ­Çϰí, ÀÓ»ó Á¤È®µµ¸¦ ³ôÀ̸ç, ±Ã±ØÀûÀ¸·Î º¸´Ù È¿°úÀûÀÎ °ü¸®¿Í ¼öÀÇÇÐ ½ÉÀ庴 ȯÀÚÀÇ ¿¹ÈÄ °³¼±¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.

µ¿¹°º´¿ø°ú Àü¹®º´¿øÀÌ ½ÉÀå³»°ú ¼­ºñ½º¸¦ È®´ëÇÏ´Â ÀÌÀ¯´Â ¹«¾ùÀΰ¡?

µ¿¹°º´¿ø, Àü¹®º´¿ø ¹× Çмú¼¾ÅÍ´Â Àü¹® Ä¡·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿¡ ´ëÀÀÇÏ°í º¹ÀâÇÑ »ç·Ê¿¡ ´ëÇÑ Ç®¼­ºñ½º ÅëÇÕ Ä¡·á¸¦ Á¦°øÇϱâ À§ÇØ ½ÉÀåÇÐ ¼­ºñ½º¿¡ ´ëÇÑ ÅõÀÚ¸¦ ´Ã¸®°í ÀÖ½À´Ï´Ù. ÀÏ¹Ý µ¿¹°º´¿ø¿¡¼­´Â ûÁø ÈÆ·Ã, ÈÞ´ë¿ë ÃÊÀ½ÆÄ, ½ÉÀüµµ µî ±âº»ÀûÀÎ ½ÉÀå °ËÁø ÅøÀ» °Ç°­°ËÁø ¹× ¸¶Ãë Àü °ËÁø¿¡ µµÀÔÇÏ¿© ½ÉÀåÁúȯÀÇ Á¶±â ¡Èĸ¦ ¹ß°ßÇÏ´Â µ¥ µµ¿òÀ» ÁÖ°í ÀÖ½À´Ï´Ù. ÀÇ·Ú º´¿øÀ̳ª Àü¹®º´¿øÀº ÇÑ °ÉÀ½ ´õ ³ª¾Æ°¡ °øÀÎµÈ Àü¹®ÀÇ¿Í ÃÖ½Å½Ä Áø´Ü½ÇÀ» °®Ãá ½ÉÀ庴 Àü¹® ºÎ¼­¸¦ ¼³¸³Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¼¾ÅÍ¿¡¼­´Â Áø´Ü»Ó¸¸ ¾Æ´Ï¶ó Àå±âÀûÀÎ ¾à¹° Ä¡·á, ½É¹ÚÁ¶À²±â À̽Ä, ü¾×°ü¸® ÇÁ·ÎÅäÄÝ, ÇÊ¿äÇÑ °æ¿ì ¼ö¼úÀû °³ÀÔÀ» ÅëÇØ ¸¸¼º½ÉÀåÁúȯÀ» °ü¸®Çϰí ÀÖ½À´Ï´Ù. ´ëÇÐ ¼öÀǰú´ëÇÐÀº ½ÉÀåÇÐ Ä¿¸®Å§·³À» °­È­ÇÏ°í ºñ±³½ÉÀåÇÐ, ¾à¹°°³¹ß, ¼±Ãµ¼º ½ÉÀ庴 Ä¡·á ¿¬±¸¸¦ È®´ëÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ Á¦¾àȸ»ç ¹× ÀÇ·á±â±â ȸ»ç¿ÍÀÇ Çù·ÂÀ» ÅëÇØ ¼Òµ¿¹°¿¡ ¸ÂÃá »õ·Î¿î Ä¡·á¹ý °³¹ßÀÌ ÁøÇàµÇ°í ÀÖ½À´Ï´Ù. ¹Ý·Áµ¿¹° º¸È£ÀÚµé·ÎºÎÅÍ ³ôÀº Æò°¡¸¦ ¹Þ°í ÀçÁø·á, Áö¼ÓÀûÀÎ ¸ð´ÏÅ͸µ, ¸ÂÃã Ä¡·á °èȹÀ» ÇÊ¿ä·Î ÇÏ´Â ¹Ý·Áµ¿¹° ÀÇ·áÀÇ ¼ºÀå ºÐ¾ß¿¡ ÁýÁßÇÔÀ¸·Î½á °æÀï·ÂÀ» È®º¸ÇÑ °æÀï º´¿øµéÀº °í°´°úÀÇ °ü°è¸¦ °­È­Çϰí, ȯÀÚÀÇ Æò»ý °¡Ä¡¸¦ Çâ»ó½ÃŰ´Â µ¥ ¼º°øÇß½À´Ï´Ù. Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù.

Àü ¼¼°è ¼öÀÇ ¼øÈ¯±â ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀº?

¼öÀÇ ¼øÈ¯±âÇÐ ½ÃÀåÀÇ ¼ºÀåÀº ¹Ý·Áµ¿¹° ¼ö ¿ªÇÐ, ±â¼ú ¹ßÀü, ÀÓ»ó Çõ½Å, ÷´Ü µ¿¹° Áø·á¿¡ ´ëÇÑ ÅõÀÚ ÀÇ¿å Áõ°¡ µî ¿©·¯ °¡Áö »óÈ£ ¿¬°üµÈ ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. Áß¿äÇÑ ÃËÁø¿äÀÎÀº Àü ¼¼°è¿¡¼­ ¹Ý·Áµ¿¹°À» Ű¿ì´Â Àα¸ Áõ°¡¿Í ¹Ý·Áµ¿¹°ÀÇ Àΰ£È­ Ãß¼¼·Î, ½ÉÀ庴°ú °°Àº ¸¸¼ºÁúȯ ¹× ³ëÈ­ °ü·Ã Áúº´¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁø °ÍÀÔ´Ï´Ù. º¸´Ù Á¤È®Çϰí Àú·ÅÇÑ Áø´Ü ÅøÀÌ Á¦°øµÊ¿¡ µû¶ó ÀϹÝÀǵéÀº ȯÀÚ¸¦ ¼±º°Çϰí Áúº´ ÁÖ±âÀÇ Ãʱ⿡ Àü¹®ÀûÀÎ ½ÉÀå Æò°¡¸¦ ¹ÞÀ» ¼ö ÀÖ´Â ±âȸ¸¦ °®°Ô µÇ¾ú½À´Ï´Ù. µ¿¹°¿ë ÀǾàǰ, ƯÈ÷ ACE ¾ïÁ¦Á¦, º£Å¸Â÷´ÜÁ¦, ÀÌ´¢Á¦, »õ·Î¿î ½ÉÀåÄ¡·áÁ¦ µîÀÇ ºÐ¾ßÀÇ ¹ßÀüÀº ½ÉÀ庴ÀÇ Àå±âÀûÀÎ °ü¸®¸¦ º¸´Ù È¿°úÀûÀ¸·Î ÇÒ ¼ö ÀÖ°Ô ÇØÁÖ°í ÀÖ½À´Ï´Ù. Àü¹® ÀÇ·á½Ã¼³°ú ¼öÀÇ ¼øÈ¯±âÇÐ ±³À° ÇÁ·Î±×·¥ÀÇ È®´ë´Â ƯÈ÷ µµ½Ã Áö¿ª¿¡¼­ÀÇ Àü¹®ÀÇ¿¡ ´ëÇÑ Á¢±Ù¼º °ÝÂ÷¸¦ ÇØ¼ÒÇÏ´Â µ¥ µµ¿òÀÌ µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¹Ý·Áµ¿¹° º¸ÇèÀÌ ´ëÁßÈ­µÇ¸é¼­ °í±Þ ½ÉÀå Ä¡·á´Â ´õ ¸¹Àº °í°´µéÀÌ °æÁ¦ÀûÀ¸·Î ½±°Ô ÀÌ¿ëÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ¿¬±¸ Çù·Â°ú ÀÓ»ó½ÃÇèµµ ¾à¹° °³¹ß ¹× Ä¡·á ÇÁ·ÎÅäÄÝÀ» °¡¼ÓÈ­Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀεéÀÌ °áÇÕµÇ¾î ¼öÀÇ ¼øÈ¯±âÇÐÀº Æ´»õ Àü¹® ºÐ¾ß¿¡¼­ Á¾ÇÕÀûÀÎ ¹Ý·Áµ¿¹° °Ç°­°ü¸®ÀÇ ÁÖ·ù ºÐ¾ß·Î º¯¸ðÇϰí ÀÖÀ¸¸ç, Áø·á¼Ò ±¸Á¶, ¼öÀÇ»ç ÈÆ·Ã ¹æ¹ý, ¹Ý·Áµ¿¹° °Ç°­°ü¸® ¹æ¹ý¿¡ ¹ÌÄ¡´Â ¿µÇâ·ÂÀº ¾ÕÀ¸·Î ´õ¿í Ä¿Áú °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

ºÎ¹®

µ¿¹° À¯Çü(¹Ý·Áµ¿¹°, »ý»ê µ¿¹°); Á¦Ç°(ÀǾàǰ, Áø´Ü¾à); ÀûÀÀÁõ(¿ïÇ÷¼º½ÉºÎÀü, ½É±Ù Áúȯ, ºÎÁ¤¸Æ, ±âŸ); ÃÖÁ¾»ç¿ëÀÚ(µ¿¹°º´¿ø & Ŭ¸®´Ð, ±âŸ)

Á¶»ç ´ë»ó ±â¾÷ÀÇ ¿¹

AI ÅëÇÕ

Global Industry Analysts´Â À¯È¿ÇÑ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AI Åø¿¡ ÀÇÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ º¯ÇõÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â LLM³ª ¾÷°è °íÀ¯ SLM¸¦ Á¶È¸ÇÏ´Â ÀϹÝÀûÀÎ ±Ô¹ü¿¡ µû¸£´Â ´ë½Å¿¡, ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾ç ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî, Àü ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»ç ¼ÒÀçÁö, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±âÁØÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇß½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¼öÀÔ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº Ç϶ô, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû, °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå °³¿ä

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Veterinary Cardiology Market to Reach US$4.2 Billion by 2030

The global market for Veterinary Cardiology estimated at US$2.7 Billion in the year 2024, is expected to reach US$4.2 Billion by 2030, growing at a CAGR of 7.5% over the analysis period 2024-2030. Companion Animals, one of the segments analyzed in the report, is expected to record a 8.8% CAGR and reach US$2.8 Billion by the end of the analysis period. Growth in the Production Animals segment is estimated at 5.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$737.4 Million While China is Forecast to Grow at 11.9% CAGR

The Veterinary Cardiology market in the U.S. is estimated at US$737.4 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$893.6 Million by the year 2030 trailing a CAGR of 11.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.6% and 7.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.9% CAGR.

Global Veterinary Cardiology Market - Key Trends & Drivers Summarized

Why Is Veterinary Cardiology Becoming a Pillar of Companion Animal Healthcare?

Veterinary cardiology is emerging as a crucial specialty in animal healthcare, driven by the increasing prevalence of heart-related conditions in companion animals and rising awareness among pet owners about the importance of early diagnosis and ongoing cardiac care. As pets live longer due to better nutrition, preventive care, and advanced medical treatments, age-related cardiovascular diseases-including congestive heart failure, arrhythmias, valve disorders, and congenital anomalies-are becoming more common. Dog breeds such as Cavalier King Charles Spaniels, Boxers, and Doberman Pinschers, as well as certain cat breeds, are genetically predisposed to heart issues, necessitating specialized care. Veterinary cardiologists and general practitioners alike are seeing a growing caseload of animals requiring diagnostics like echocardiography, electrocardiograms (ECGs), radiographic imaging, and cardiac biomarker testing. Pet owners, increasingly viewing their animals as family members, are more willing to pursue advanced diagnostic and therapeutic interventions to improve quality of life and extend longevity. This growing emphasis on animal wellness and specialized care is significantly expanding the demand for veterinary cardiology services across urban clinics, specialty hospitals, and academic veterinary centers worldwide.

How Are Innovations in Diagnostics and Imaging Enhancing Cardiac Care for Animals?

Technological innovation is reshaping veterinary cardiology, enabling earlier detection, more accurate diagnosis, and better monitoring of cardiovascular diseases in animals. Modern echocardiography machines now offer high-resolution, Doppler-based imaging tailored for veterinary use, allowing clinicians to assess blood flow, valve function, and chamber dimensions with high precision. Portable and wireless ECG systems are making it easier to perform heart rhythm analysis in clinical or even home-based settings, improving access to diagnostics in general practices and mobile services. Cardiac biomarkers such as NT-proBNP and troponin are being increasingly utilized for screening, staging, and monitoring heart disease, providing a minimally invasive complement to imaging diagnostics. Advanced imaging tools like 3D echocardiography, computed tomography (CT), and magnetic resonance imaging (MRI) are becoming more prevalent in veterinary referral centers, especially for complex cases. Telemedicine is also playing a growing role in veterinary cardiology, enabling practitioners to consult with specialists remotely and receive rapid interpretations of ECGs or echo results. These technological developments are streamlining workflows, enhancing clinical accuracy, and ultimately contributing to more effective management and improved outcomes in veterinary cardiac patients.

Why Are Veterinary Clinics and Specialty Hospitals Expanding Cardiology Services?

Veterinary clinics, specialty hospitals, and academic centers are increasingly investing in cardiology services to meet rising demand for specialized care and to offer full-service, integrated treatment for complex cases. General veterinary practices are incorporating basic cardiac screening tools-such as auscultation training, handheld ultrasound devices, and ECGs-into wellness exams and pre-anesthetic screenings, helping to catch early signs of cardiac disease. Referral and specialty hospitals are going a step further, establishing dedicated cardiology departments with board-certified specialists and state-of-the-art diagnostic suites. These centers are not only diagnosing but also managing chronic cardiac conditions with long-term pharmacologic therapy, pacemaker implantation, fluid management protocols, and surgical interventions when needed. Academic veterinary schools are strengthening cardiology curricula and expanding research in comparative cardiology, drug development, and congenital heart defect repair. Additionally, collaboration with pharmaceutical and medical device companies is leading to the development of new treatment options tailored for small animals. Clinics offering advanced cardiac care are gaining a competitive edge by addressing a growing segment of pet healthcare that is deeply valued by pet owners and often requires repeat visits, ongoing monitoring, and personalized treatment plans-resulting in stronger client relationships and higher lifetime patient value.

What’s Driving the Global Growth of the Veterinary Cardiology Market?

The growth in the veterinary cardiology market is driven by several interrelated factors tied to pet demographics, technological progress, clinical innovation, and increasing consumer willingness to invest in advanced animal care. A significant driver is the global rise in pet ownership and the growing trend of pet humanization, which has led to greater awareness of chronic and age-related conditions like heart disease. The availability of more accurate and affordable diagnostic tools is empowering general practitioners to screen and refer patients for specialized cardiac evaluations earlier in the disease cycle. Advancements in veterinary pharmaceuticals-especially in areas like ACE inhibitors, beta blockers, diuretics, and novel heart medications-are enabling more effective long-term management of cardiac conditions. The expansion of specialty care facilities and veterinary cardiology training programs is helping to bridge the gap in specialist access, particularly in urban centers. Furthermore, the growth of pet insurance coverage is making advanced cardiac care financially accessible to a larger client base. Research collaborations and clinical trials are also accelerating drug development and treatment protocols. Together, these factors are propelling veterinary cardiology from a niche specialty to a mainstream component of comprehensive pet healthcare, with growing influence on how clinics are structured, how veterinary professionals are trained, and how pet health is managed in the years to come.

SCOPE OF STUDY:

The report analyzes the Veterinary Cardiology market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Animal Type (Companion Animals, Production Animals); Product (Pharmaceuticals, Diagnostics); Indication (Congestive Heart Failure, Myocardial Disease, Arrhythmias, Others); End-Use (Veterinary Hospitals & Clinics, Others)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 43 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â